MedTrace Logo

Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS

NCT02434055 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-06-18

No results posted yet for this study

Summary

Purpose: To evaluate the accuracy of the AVERT PLUS to monitor contrast volume used during angiographic procedures.

Research Design: The AVERT PLUS is an FDA 510K cleared device which consists of a contrast delivery modulator designed to reduce unnecessary contrast dye delivery to the patient during angiography (coronary or peripheral) and a concomitant system to precisely measure contrast volume delivered to the patient. This will be a first in man prospective observational study of the accuracy of this system to quantify contract volume used during clinically indicated angiography in the cardiac catheterization laboratory.

Conditions

  • Extravasation of Contrast Media

Interventions

DEVICE

AVERT PLUS

Sponsors & Collaborators

  • Osprey Medical, Inc

    collaborator INDUSTRY

  • Anand Prasad

    lead OTHER

Principal Investigators

  • Michele Shepard · Osprey Medical, Inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434055 on ClinicalTrials.gov